Spinal Muscular Atrophy and School Transitions
Exploring Educational Transitions in Children and Young People With Spinal Muscular Atrophy: A Qualitative Study of Patient and Family Experiences.
1 other identifier
observational
20
1 country
1
Brief Summary
A qualitative questionnaire-based study to explore the experiences of children and young people with Spinal Muscular Atrophy (SMA) and their families regarding school transition and educational participation. The study objectives: To identify barriers to successful educational transition. To advocate for patients and families during the transitional process. To explore experiences of inclusion, access and support within school settings. To understand the coordination between education, healthcare and support services. To inform the development of practical, patient-centred guidance to improve educational transitions for children and young people with SMA.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Aug 2026
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 17, 2026
CompletedFirst Posted
Study publicly available on registry
July 22, 2026
CompletedStudy Start
First participant enrolled
August 10, 2026
ExpectedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2026
Study Completion
Last participant's last visit for all outcomes
February 28, 2027
July 22, 2026
July 1, 2026
3 months
July 17, 2026
July 17, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Completion of the questionnaire to explore the experiences of children and young people with SMA and their families regarding school transition and educational participation.
3 families will be invited to take place in a focus group discussion. Each family will be interviewed in a family unit on Microsoft Teams. These discussions will enable the development of a questionnaire which will be sent to 12 families to complete.
1 month to complete the focus groups. 1 month to develop the questionnaire. 1 month to send questionnaires to 12 families and allow for the responses back.
Study Arms (2)
Focus group
Discussion regarding the development of a questionnaire
Completing questionnaire
Eligibility Criteria
Participants with a genetic diagnosis of Spinal Muscular Atrophy 1, 11 or 111.
You may qualify if:
- Genetically confirmed diagnosis of Spinal Muscular Atrophy 1, 11 or 111
- In education, in either primary school, secondary school or further education
- Access to internet and either a smart phone, tablet or computer.
You may not qualify if:
- Not in education
- Not able to comply with the consent process
- Not cognitively able to complete the questionnaire.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Robert Jones & Agnes Hunt Orthopaedic Hospital
Oswestry, Shropshire, SY10 7AG, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Nicholas Emery
Neuromuscular Clinical Specialist Physiotherapist
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- FAMILY BASED
- Time Perspective
- PROSPECTIVE
- Target Duration
- 1 Month
- Sponsor Type
- OTHER GOV
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 17, 2026
First Posted
July 22, 2026
Study Start (Estimated)
August 10, 2026
Primary Completion (Estimated)
November 1, 2026
Study Completion (Estimated)
February 28, 2027
Last Updated
July 22, 2026
Record last verified: 2026-07